Follow
Rimma Goldberg
Rimma Goldberg
Senior Lecturer, Monash University. Gastroenterologist, Monash Health.
Verified email at monash.edu - Homepage
Title
Cited by
Cited by
Year
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
JB Canavan, C Scottā, A Vossenkämper, R Goldberg, MJ Elder, I Shoval, ...
Gut 65 (4), 584-594, 2016
1672016
The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD
R Goldberg, N Prescott, GM Lord, TT MacDonald, N Powell
Nature reviews Gastroenterology & hepatology 12 (5), 271-283, 2015
912015
Interleukin 6 increases production of cytokines by colonic innate lymphoid cells in mice and patients with chronic intestinal inflammation
N Powell, JW Lo, P Biancheri, A Vossenkämper, E Pantazi, AW Walker, ...
Gastroenterology 149 (2), 456-467. e15, 2015
772015
Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis
HL Philpott, S Nandurkar, F Thien, S Bloom, E Lin, R Goldberg, ...
Internal Medicine Journal 45 (9), 939-943, 2015
392015
Toxicity and response to thiopurines in patients with inflammatory bowel disease
R Goldberg, PM Irving
Expert review of gastroenterology & hepatology 9 (7), 891-900, 2015
382015
Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease
K Soderquest, A Hertweck, C Giambartolomei, S Henderson, R Mohamed, ...
PLoS genetics 13 (2), e1006587, 2017
372017
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres
MA Samaan, P Pavlidis, E Johnston, B Warner, J Digby-Bell, ...
Frontline Gastroenterology 8 (3), 196-202, 2017
352017
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities
SX Cho, I Rudloff, JC Lao, MA Pang, R Goldberg, CB Bui, CA McLean, ...
Nature communications 11 (1), 1-19, 2020
292020
Correction of defective T-regulatory cells from patients with Crohn’s disease by ex vivo ligation of retinoic acid receptor-α
R Goldberg, C Scotta, D Cooper, E Nissim-Eliraz, E Nir, S Tasker, ...
Gastroenterology 156 (6), 1775-1787, 2019
262019
Thiopurine metabolite testing in inflammatory bowel disease
R Goldberg, G Moore, G Cunningham, J Schulberg, P Marsh, S Brown, ...
Journal of gastroenterology and hepatology 31 (3), 553-560, 2016
162016
Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B
R Goldberg, E Smith, S Bell, A Thompson, PV Desmond
Internal Medicine Journal 7 (43), 835-836, 2013
162013
Recombinant activated factor VII for a warfarinised Jehovah’s Witness with an acute subdural haematoma
R Goldberg, KJ Drummond
Journal of Clinical Neuroscience 15 (10), 1164-1166, 2008
112008
ECCO topical review: refractory inflammatory bowel disease
T Raine, B Verstockt, U Kopylov, K Karmiris, R Goldberg, R Atreya, ...
Journal of Crohn's and Colitis 15 (10), 1605-1620, 2021
72021
Resolving intestinal fibrosis through regenerative medicine
R Schwab, R Lim, R Goldberg
Current Opinion in Pharmacology 49, 90-94, 2019
72019
Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero
E Flanagan, R Prentice, EK Wright, PR Gibson, AL Ross, J Begun, ...
Alimentary Pharmacology & Therapeutics 55 (6), 700-704, 2022
62022
How accurate are hospital scales?
R Goldberg, G Hebbard
The Medical Journal of Australia 194 (12), 665, 2011
32011
A Crohn’s Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling
R Goldberg, JN Clough, LB Roberts, J Sanchez, S Kordasti, N Petrov, ...
Journal of Crohn's and Colitis 15 (12), 2054-2065, 2021
22021
PTH-114 Dedicated endoscopic ibd surveillance list improves adherence to guidelines
R Goldberg, S Fong, M Samaan, J DigbyBell, E Johnston, S Anderson, ...
Gut 66 (Suppl 2), A262-A263, 2017
12017
P378. Predictors of sub-therapeutic infliximab or adalimumab trough levels and anti-drug antibodies and their influence on therapeutic decisions
R Goldberg
Journal of Crohn's and Colitis 8, S223, 2014
12014
P378. Predictors of sub-therapeutic infliximab or adalimumab trough levels and anti-drug antibodies and their influence on therapeutic decisions
R Goldberg
Journal of Crohn's and Colitis 8, S223, 2014
12014
The system can't perform the operation now. Try again later.
Articles 1–20